Navigation Links
Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
Date:12/8/2009

BALTIMORE, Dec. 8 /PRNewswire/ -- Ameritox, the U.S. leader in pain medication monitoring solutions, has announced the appointment of Jay B. Zimmerman as Chief Operating Officer. Zimmerman will oversee R&D, infrastructure and expansion initiatives, including driving efficiencies within existing operations, overseeing the development of new technologies, and ensuring process standardization and quality control across all facilities, including the Midland, TX laboratory and the new laboratory opening in Greensboro, NC in 2010. Jay joined Ameritox on September 1, 2009 and will be based at its headquarters in Baltimore, MD.

"Jay is bringing his expertise in building high quality infrastructure and scalability to bear at a critical moment in our growth," said Ancelmo E. Lopes, CEO of Ameritox. "We welcome his leadership as we expand processing capacity with our new laboratory in North Carolina and prepare to launch new technologies that will enhance our current offerings, furthering our ability to provide physicians with critical tools to achieve optimal patient outcomes in Pain Medication Monitoring."

For more than 20 years, Mr. Zimmerman has managed clinical research programs in a variety of settings. He began his career at Massachusetts General Hospital, the flagship Harvard University Hospital, where he served as Administrative Director in the Center for Imaging and Pharmaceutical Research. Mr. Zimmerman was later appointed Senior Vice President and Chief Operating Officer of WorldCare, Inc., a clinical research organization serving Proctor & Gamble, Hoffmann La Roche, Novartis and other leading pharmaceutical companies.

At Perceptive Informatics, Inc., a subsidiary of the biopharmaceutical services provider PAREXEL International, Jay served as Vice President of the Medical Imaging Division. During his tenure there he oversaw the company's contract research and consulting services for pharmaceutical, biotechnology and medical device customers in their use of medical imaging as an endpoint in clinical trials - contributing to dozens of successful regulatory submissions.

Most recently Mr. Zimmerman founded North Point Imaging Research, a start up venture providing technology and services using medical imaging as an endpoint in the clinical development process.

Jay Zimmerman received his Masters of Education in Administrative Policies Studies, Hospital Administration from the University of Pittsburgh, and a Bachelor of Science in Biology/Education from the University of South Carolina.

About Ameritox

Ameritox is the nation's leader in pain medication monitoring solutions(SM), offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers Rx Guardian(SM), the most thorough and personalized lab service available and the only pain medication testing program with a proprietary methodology to help physicians assess whether patients are taking their pain medication as directed. Medication monitoring helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, MD, with laboratory facilities in Midland, TX and a second laboratory opening early 2010 in Greensboro NC.

AMERITOX, the AMERITOX logo, RX GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE are trademarks of Ameritox.

Contact: Jennifer Paganelli of Edelman PR Worldwide, +1-347-658-8290

SOURCE Ameritox


'/>"/>
SOURCE Ameritox
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. Curemark Appoints Preeminent Pediatrics Gastroenterologist
5. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
8. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
9. NovaRx Appoints Industry Veteran as President and COO
10. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
11. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... with extensive sequencing and genomics experience, as Vice President of North American Capital Sales ... be responsible for leading the sales team in the commercialization of the HTG EdgeSeq ...
Breaking Medicine News(10 mins):